Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KLHL29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM175B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102723709 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC16A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF527 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSKH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRS1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00052 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CABYR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102723542 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TANC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00176 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS37C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on